FDA — authorised 3 July 2014
- Application: NDA206256
- Marketing authorisation holder: ACROTECH BIOPHARMA
- Local brand name: BELEODAQ
- Indication: POWDER — INTRAVENOUS
- Status: approved
🇺🇸 Belinostat Injection in United States
FDA authorised Belinostat Injection on 3 July 2014
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Belinostat Injection approved in United States?
Yes. FDA authorised it on 3 July 2014.
Who is the marketing authorisation holder for Belinostat Injection in United States?
ACROTECH BIOPHARMA holds the US marketing authorisation.